Mysuru, India

Wajid Sajjad Jafri

This inventor holds 1 USPTO granted patent. Top assignee: Max India Limited. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wajid Sajjad Jafri. Retrieved from https://idiyas.com/inventor/wajid-sajjad-jafri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wajid Sajjad Jafri: Innovator in Pharmaceutical Processes

Introduction

Wajid Sajjad Jafri is a notable inventor based in Mysore, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for drug preparation. His innovative work has led to advancements that improve existing methodologies.

Latest Patents

Wajid holds a patent for a process titled "Process for preparing carbamazepine from iminostilbene." This process involves the reaction of iminostilbene with urea in a protonating medium. The method showcases improvements over prior art processes involving iminostilbene. Carbamazepine, the end product, is recognized for its applications as a muscle relaxant, anticonvulsant, and antidepressant drug. He has 1 patent to his name.

Career Highlights

Wajid is currently employed at Max India Limited, where he continues to engage in innovative research and development. His work at the company reflects his commitment to enhancing pharmaceutical processes and contributing to the healthcare industry.

Collaborations

Wajid collaborates with talented professionals in his field, including Ketan Dhansukhlal Vyas and Ashok Krishna Kulkarni. These collaborations foster a creative environment that encourages the exchange of ideas and expertise.

Conclusion

Wajid Sajjad Jafri is a distinguished inventor whose work in pharmaceutical processes has the potential to impact the industry significantly. His innovative approach to drug preparation exemplifies the importance of research and development in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…